title: Beta 4 integrin subunit expression is downregulated in low metastatic carcinoma variants.
abstract: Organization and expression of the gene coding for beta 4 integrin subunit were investigated in murine carcinoma lines endowed with low and high metastatic potential maintained both in vivo and in vitro. Probes corresponding to either the extracellular or the cytoplasmic domains of the protein were generated and employed for Southern and Northern blot hybridization experiments. Southern blot analysis demonstrates a restriction fragment-length polymorphism between BALB/c and C57BI/6J DNAs. The different genomic organization of the beta 4 gene apparently does not generate variation in mRNA length. Northern blot analysis reveals a 7-kb transcript encoding full-length beta 4 protein and shorter transcripts that apparently correspond to nonfunctional mRNAs. In carcinoma cells endowed with low metastatic capacity, the 7-kb mRNA cannot be revealed in spite of the presence of shorter transcripts. In contrast, the 7-kb transcript is always present in tumor cells endowed with high metastatic capacity. Accordingly, the beta 4 protein is detectable, either by immunofluorescence or by Western blot analyses, only in highly metastatic carcinoma cells. In conclusion, the data presented show that in these murine carcinoma cell lines (i) the 7-kb mRNA is associated with a more invasive phenotype, and (ii) missing expression of the beta 4 integrin subunit in low metastatic carcinoma cells depends, at least in part, on mechanisms acting at a post-transcriptional level. The possibility that beta 4 subunit expression is a consequence of specific differentiation stages of lung carcinoma cells is discussed.
authors.affiliation: Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Rome, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Cimino
authors.forename: D
authors.initials: D
authors.lastname: Perrotti
authors.forename: G
authors.initials: G
authors.lastname: D'Agostino
authors.forename: R
authors.initials: R
authors.lastname: Falcioni
authors.forename: A
authors.initials: A
authors.lastname: Sacchi
mesh_terms: D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000235:genetics / Q000473:pathology*; D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis* / Q000737:chemistry / Q000235:genetics; D015139:Blotting, Southern; D015153:Blotting, Western; D018827:Carcinoma, Lewis Lung / Q000235:genetics* / Q000473:pathology; D002454:Cell Differentiation; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D039663:Integrin beta4; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis / Q000235:genetics*; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000737:chemistry / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D012334:RNA, Neoplasm / Q000032:analysis; D014407:Tumor Cells, Cultured
chemical_list: D015703:Antigens, CD; D039663:Integrin beta4; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm